Anaphylactic Shock Case Presentation
Anaphylactic Shock Case Presentation
Anaphylactic Shock Case Presentation
• Risk Factors
II. Clinical Summary/ Abstract
• PERSONAL DATA:
• Name : Roderick Gando Abella
• Age : 52
• Address : Radio Pantoc Barangay 10, Lucena City
• Gender : Male
• Status : Single
• Religion : Roman Catholic
• Work : Licensing Officer II at Lucena Government Complex
• Cc : Vomiting for 2 days
• AP : Dr. Erwin Reyes- Pulmonologist
II. Clinical Summary/ Abstract
• Events leading to consultation:
-Vomiting for 2 days
Vital Signs taken at ER MCDGH
T: 40
P: 101
R: 30
BP:Unapreciated
History of Past medical Illness
• Known Diabetic type 2 (Non-Compliant to medications)
• No Known allergies
• Occasional Alcohol intake
• Covid Vaccines:
• AstraZeneca: May 20, 2021 Booster- AstraZeneca: December 29, 2021
July 26, 2021 Pfizer: July 29, 2022
History of Present Illness
• Nov. 8, 2022
• Patient came home from work earlier that usual, no complaint. Able to eat dinner Dinuguan. After eating dinner, (+)
vomiting 3-4x, no meds taken, (+) abdominal pain
• Nov. 9, 2022
• Persistence of abdominal pain, (-) vomiting but with LBM, approximately 3-4x/ day. Able to eat lunch. Noted to have
facial edema.
• Around 8pm, with progression of edema, (+) generalized rashes noted, with decrease level of sensorium, GCS 8
(E2,V1,M5), (+) DOB
• At Emergency Room
• Still GCS 8, Bp unappreciated, HR: 101, RR: 30, T: 40, O2 Sat: 70% at room air, Hooked to O2 via NRM at 5-10 LPM
• (+) angioedema (+) rashes on face
• Epinephrine 0.3ml IM, Diphenhydramine IM, Hydrocortisone 250mg IV- GIVEN
• Dobutamine and Norepinephrine drip started- BP: 70/40, Standby Intubation– Admitted to ICU
• Admitted to ICU
• 1am GCS 13 (E3,V4,M6), BP: 70/40, titrated Norepi and dobu. Still with facial edema
• Noted elevated CKMB: 105 Trop I: 495.20 Na: 118– ACS protocol done Aspirin 80mg 4 tabs, Clopidogrel 75mg tab 4 tabs,
Enoxaparin 0.44cc SQ OD
• RBS persistently High
III. Assessment
PHYSICAL ASSESSMENT:
• Stretcher GENITOURINARY:
CONSTITUTION: • (-) Discharge
• Fever NEUROLOGIC:
SKIN: GCS: 8
• Rashes Eye Opening : 2
• Erythema Verbal Response : 1
• Angioedema Motor Response : 5
• Fair skin turgor
RESPIRATORY:
• Decreased breath sound
• Labored in breathing
CARDIOVASCULAR:
• (-) Murmur
GASTROINTESTINAL:
• Nausea and vomiting
ANATOMY
PATHOPHYSIOLOGY
Anaphylactic Shock
Sensitization
Immunologic
Orally Ingestion
(Dinuguan)
• Anaphylactoid Reaction
(non-immunological)
Diagnostic/Lab Exams/Tests
Laboratory Indication
Tests
Complete • Lipase is the preferred laboratory test for diagnosing acute pancreatitis, as it
Blood Count is the most sensitive and specific marker for pancreatic cell damage.
(CBC) Additional laboratory testing, such as complete blood count (CBC) and
lactate dehydrogenase (LDH) tests, are useful to obtain prognostic
information.
Chest X-Ray • An ultrasound of your abdomen will show the pancreas and the surrounding
area, including your liver. It can show if a tumor is present and its size
Whole • An ultrasound of your abdomen will show the pancreas and the surrounding
Abdomen area, including your liver. It can show if a tumor is present and its size
Ultrasound
Diagnostic/Lab Exams/Tests
Potassium 3.5-5.1 3.20 • A high potassium can make your heart beat irregularly, which in the worst
cases can cause heart attack.
• A low potassium level can make muscles feel weak, cramp, twitch, or even
become paralyzed, and abnormal heart rhythms may develop.
Pulmonary alkalosis
GENERIC NAME SPECIFIC INDICATION CONTRAINDICATION SIDE EFFECT NURSING
BRAND NAME ACTION RESPONSIBILITIES
DOSAGE
FREQUENCY
EPINEPRINE
0.3ML IM
STAT
DIPHENHYDRAMINE
IM
STAT
HYDROCORTISONE
250MG IV
STAT
ATROVENT NEB
Q4
OMEPRAZOLE
(PROSEC)
10mg IV
ASPIRIN
80mg 1 TAB
OD
CLOPIDOGREL
75mg 1 TAB
OD
GENERIC NAME SPECIFIC INDICATION CONTRAINDICATION SIDE EFFECT NURSING
BRAND NAME ACTION RESPONSIBILITIES
DOSAGE
FREQUENCY
ATORVASTATIN
80mg 1 TAB
ODHS
ENOXAPARIN 0.4CC
SQ
OD
PARACETAMOL
(BIOGESIC)
300mg IV
Q4 PRN FOR FEVER
TRIMETAZIDINE
35mg 1TAB
BID
HEMOSTAN
500mg IV
Q8
VITAMIN K
1 amp
Q8 X 3 DOSES
VIATREX
1gm IV
Q12
GENERIC NAME SPECIFIC INDICATION CONTRAINDICATION SIDE EFFECT NURSING
BRAND NAME ACTION RESPONSIBILITIES
DOSAGE
FREQUENCY
CLINDAMYCIN
900MG IV
Q8
CEFAZOLIN
2gm IV
Q24
Nursing Care Plan
Assessment Nursing Diagnosis Planning Intervention Rationale Evaluation